Here, you’ll have the opportunity to share your findings with a global audience and discuss your ideas with experts from around the globe. In addition to presenting at DDW 2023, accepted abstracts ...
AUSTIN, Texas, April 29, 2026 (GLOBE NEWSWIRE)-- Cristcot, a clinical-stage pharmaceutical company advancing targeted therapies for gastrointestinal diseases, today announced that the Company will ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its three posters at the ...
THE WOODLANDS, TX, April 29, 2026 (GLOBE NEWSWIRE)-- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted ...
INCHEON, South Korea, April 21, 2026 /PRNewswire/ -- Celltrion, Inc. today announced that seven abstracts will be presented at the 2026 Digestive Disease Week® (DDW) Annual Meeting, taking place May 2 ...
BRIDGEWATER, NJ / ACCESS Newswire / May 1, 2025 / Tharimmune, Inc., (Nasdaq:THAR) ("Tharimmune" or the "Company") a clinical-stage biopharmaceutical company focused on developing innovative ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, is pleased to announce that it will present data from two studies highlighting the ...
(MENAFN- GlobeNewsWire - Nasdaq) Oral presentation on the impact of concomitant steroid use in ulcerative colitis (UC) scheduled for May 5, 2026, at 9:30am CDT AUSTIN, Texas, April 29, 2026 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results